ABSTRACTS AND PUBLICATIONS

Abstracts:

1. Markers Of The Increase In Thrombin Production In Multiple Gestation. XVIIIth Congress of The International Society on Thrombosis and Haemostasis, Paris, France, July 6-12, 2001

2. Increased Thrombin Generation As Per Endogenous Thrombin Potential (ETP), Coagulation Activation Markers (TpP, TAT, And PF1.2), And TAFI Levels In Subjects Treated With Estrogen Hormone Replacement (HRT). XVIIIth Congress of The International Society on Thrombosis and Haemostasis, Paris, France, July 6-12 2001

3. Comparison Of ELISA For Soluble Fibrin Polymer (TpP) And D-Dimer In Patients With Renal Failure Or Malignancy (Not In Remission) And Not Having Clinical Evidence For Active Venous Thromboembolism. XVIIIth Congress of The International Society on Thrombosis and Haemostasis, Paris, France, July 6-12 2001

4. TpP Plasma Levels As A New Marker Of Thrombophilia In Patients With Cardioembolic Stroke. Italian Congress on Stroke, Naples, Italy, 2000

5. Thrombophilic Pregnant Women Manifest Early Increased Thrombin Generation Along With An Increased Rate of Adverse Pregnancy Outcomes. 48th Annual Meeting of the Society for Gynecologic Investigation, Toronto (Canada), March 14-17, 2000

6. Preeclampsia is Associated with Decreased Thrombin Activity in the Second Trimester. 2000 Annual Meeting of Society for Maternal-Fetal Medicine, Miami Beach, Florida, January 31 – February 5, 2000

7. Use of Thrombus Precursor Protein (TpP) To Exclude Deep Vein Thrombosis. XVIIth Congress of the International Society of Thrombosis and Haemostasis, Washington, D.C., August 14 - 21, 1999

8. The Use of Thrombin Precursor Protein (TpP), D-Dimer (DD), Prothrombin Fragment 1.2 (PF1.2), and Thrombin Antithrombin (TAT) in the Exclusion of Proximal Deep Vein Thrombosis (PDVT) and Pulmonary Embolism (PE) in the Emergency Department (ED). XVIIth Congress of the International Society of Thrombosis and Haemostasis, Washington, D.C., August 14 - 21, 1999

9. The Thrombus Precursor Protein (TpP) and Other Activation Markers Levels in Thrombophilia Patients with and without Anticoagulant (AC) Treatment. XVIIth Congress of the International Society of Thrombosis and Haemostasis, Washington, D.C., August 14 - 21, 1999

10. Thrombus Precursor Protein (TpP) Levels and Other Activation Markers in Hypercoagulation Patients. XVIIth Congress of the International Society of Thrombosis and Haemostasis, Washington, D.C., August 14 - 21, 1999

11. Predischarge Plasma Levels of Soluble Fibrin Polymers (TpPJ) Correl ate with the Development of Deep Vein Thrombosis (DVT) After Elective Neurosurgery. XVIIth Congress of the International Society of Thrombosis and Haemostasis, Washington, D.C., August 14 - 21, 1999

12. Preliminary Results Back Early Blood Clot Test. Clinica (January 1999).

13. Hemostatic Markers and Catecholamine Release During Exercise. 47th Annual Scientific Session of American College of Cardiology, Atlanta, Georgia, March 29 – April 1, 1998

14. The Determination of Soluble Fibrin Polymers In Surgical Patients. XIVth Congress of the International Society of Thrombosis and Haemostasis, Birmingham- United Kingdom, 1996

15. A Method For Monitoring Formation Of Arterial Thrombosis During PTCA Identification Of Thrombus Precursor Protein (TpP) In The Unstable PTCA Patient. European Society of Cardiology, Birmingham-United Kingdom, August 25-29, 1996.

PUBLICATIONS:

1. Clinical Usefulness of Thrombus Precursor Protein (TpP)™ In The Diagnosis Of Ischemic Heart Disease And Changes of TpP After LMWH Therapy. KL Song, HK Kim, D Choi, N Chung and SS Kim. Proceedings of the 3rd Interational Congress on Coronary Artery Disease 2000; 443-447. Monduzzi Editore SpA, publisher.

2. Decreased TpP Levels Linked to Preeclampsia. Clinical Lab Letter, April 15, 2000, Vol 21, No. 7.

3. Heparin Blunts Endotoxin-Induced Coagulation Activation. T. Pernerstorfer, et al. Circulation December 21/28, 1999

4. Lepirudin Blunts Endotoxin-Induced Coagulation Activation. T.Pernerstorfer, et al. Blood, 1 March 2000, Vol 95, No 5

5. The Use of Thrombus Precursor Protein, D-dimer, Prothrombin Fragment 1.2, and Thrombin Antithrombin in the Exclusion of Proximal Deep Vein Thrombosis and Pulmonary Embolism. S. LaCapra, et al. Blood Coagulation and Fibrinolysis 2000, Vol 11, No 4

6. Endotoxin-Induced Activation of the Coagulation Cascade in Humans: Effect of Acetylsalicylic Acid and Acetaminophen. Artheriosclerosis, Thrombosis and Vascular Biology (October 1999)

7. Thrombus Precursor Protein as a Measure of Prothrombotic Activity in a Patient with Factor VIII Inhibitor Treated with Activated Prothrombin Complex Concentrates. Thromb Haemost 1999; 82: 152-3 (April 1999)

8. Preoperative Plasma Levels of Soluble Fibrin Polymers Correlate with the Development of Deep Vein Thrombosis After Elective Neurosurgery. Blood Coagulation and Fibrinolysis (January 1999)

9. Acute Myocardial Infarction During Exercise., Ens, Clinical Hemostasis Review, (December 1998)

10. An Immunological Assay for the Determination of Circulating Levels of Thrombus Precursor Protein., Carville et al, Clinical Hemostasis Review (February 1997)

11. Thrombus Precursor ProteinJ and the Measurement of Thrombosis in Patients with Acute Chest Pain Syndrome., Laurino et al, Annals of Clinical and Laboratory Science, 27:5, (1997)

12. Thrombus precursor protein (TpPJ): Marker of Thrombosis Early in the Pathogenesis of Myocardial Infarction., Carville et al, Clinical Chemistry, 42:9, 1537-1541, (1996)

13. A Monoclonal Antibody which Recognizes an Epitopic Region Unique to the Intact Fibrin Polymeric Structure., Gargan et al, Fibrinolysis, 7, 275-283, (1993)

Be sure to check back!
Abstracts and publications will be added
to this page as they become available.